Aspirin is NOT recommended for DVT prevention prior to ultrasound
The evidence provided does not support using aspirin for DVT prophylaxis in the general clinical scenario you're describing. Aspirin (81-325 mg daily) is only recommended for VTE prophylaxis in a very narrow population: patients with multiple myeloma at low risk for VTE 1. Outside of this specific indication, aspirin is not considered effective VTE prophylaxis.
Why Aspirin Should Not Be Used
The guideline evidence is clear and consistent:
Aspirin failed to prevent VTE in healthy populations: The Women's Health Study showed no significant difference in VTE incidence between aspirin 100 mg and placebo in healthy women 1
Conflicting evidence for secondary prevention only: While some studies showed aspirin reduced VTE recurrence after completing 6-12 months of anticoagulation (14% vs 22% recurrence), the ASPIRE trial failed to show significant benefit (4.8% vs 6.5%, p=0.09) 1
Explicitly not recommended for cancer patients: Given the conflicting results and exclusion of cancer patients from trials, aspirin cannot be recommended for VTE treatment or prevention in patients with cancer 1
What You Should Use Instead
For DVT prophylaxis prior to diagnostic ultrasound, use appropriate anticoagulation based on clinical context:
Hospitalized Medical Patients
- Enoxaparin 40 mg subcutaneous once daily, OR
- Dalteparin 5,000 units subcutaneous once daily, OR
- Unfractionated heparin 5,000 units subcutaneous every 8 hours 2
Surgical Patients
- Enoxaparin 40 mg once daily (started 10-12 hours preoperatively or 2-4 hours postoperatively)
- Dalteparin 5,000 units once daily (with similar timing)
- Fondaparinux 2.5 mg once daily beginning 6-8 hours postoperatively 2
Critical Pitfall to Avoid
Do not confuse the orthopedic surgery literature (which comprises most of the research evidence provided) with general DVT prophylaxis. The studies showing aspirin efficacy 3, 4, 5, 6, 7, 8, 9, 10 are specific to post-arthroplasty or trauma settings with structured protocols, not for general DVT prevention prior to diagnostic imaging.
The stroke guidelines 11 address aspirin for arterial thrombosis prevention (81-325 mg daily for stroke/TIA), which is an entirely different indication than venous thromboembolism prophylaxis.
Bottom line: Use LMWH, fondaparinux, or unfractionated heparin for DVT prophylaxis—not aspirin.